These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 20221655)

  • 1. Parkinson's disease: oxidative stress and therapeutic approaches.
    Surendran S; Rajasankar S
    Neurol Sci; 2010 Oct; 31(5):531-40. PubMed ID: 20221655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathogenesis of Parkinson's disease.
    Gandhi S; Wood NW
    Hum Mol Genet; 2005 Sep; 14(18):2749-55. PubMed ID: 16126732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurodegenerative pathways in Parkinson's disease: therapeutic strategies.
    Cardoso SM; Moreira PI; Agostinho P; Pereira C; Oliveira CR
    Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):405-19. PubMed ID: 16101557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of N-acetylaspartic acid induces oxidative stress to contribute in disease pathophysiology.
    Surendran S; Bhatnagar M
    Int J Neurosci; 2011 Jun; 121(6):305-9. PubMed ID: 21348802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson's disease.
    Ahlskog JE
    Mov Disord; 2005 Mar; 20(3):271-82. PubMed ID: 15580550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are heat shock proteins therapeutic target for Parkinson's disease?
    Luo GR; Chen S; Le WD
    Int J Biol Sci; 2006 Oct; 3(1):20-6. PubMed ID: 17200688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione, iron and Parkinson's disease.
    Bharath S; Hsu M; Kaur D; Rajagopalan S; Andersen JK
    Biochem Pharmacol; 2002 Sep; 64(5-6):1037-48. PubMed ID: 12213603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative and nitrosative stress in Parkinson's disease.
    Tsang AH; Chung KK
    Biochim Biophys Acta; 2009 Jul; 1792(7):643-50. PubMed ID: 19162179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathogenesis, experimental models and new therapeutic strategies for Parkinson's disease.
    Yamashita H; Matsumoto M
    Regen Med; 2007 Jul; 2(4):447-55. PubMed ID: 17635051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does smoking reduce the risk of Parkinson's disease through stimulation of the ubiquitin-proteasome system?
    Chapman MA
    Med Hypotheses; 2009 Dec; 73(6):887-91. PubMed ID: 19540050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonistic pleiotropic effects of nitric oxide in the pathophysiology of Parkinson's disease.
    Tripathy D; Chakraborty J; Mohanakumar KP
    Free Radic Res; 2015; 49(9):1129-39. PubMed ID: 25968946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
    Verma R; Nehru B
    Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does neurotrophic factor benefit to PD therapy via co-function with ubiquitin-proteasome system?
    Niu C; Zhang J; Mei J; Fu X
    Med Hypotheses; 2011 Apr; 76(4):589-92. PubMed ID: 21288653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of hesperidin in a model of Parkinson's disease induced by 6-hydroxydopamine in aged mice.
    Antunes MS; Goes AT; Boeira SP; Prigol M; Jesse CR
    Nutrition; 2014; 30(11-12):1415-22. PubMed ID: 25280422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease.
    McNaught KS; Jnobaptiste R; Jackson T; Jengelley TA
    Synapse; 2010 Mar; 64(3):241-50. PubMed ID: 19924695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plant Polyphenols as Neuroprotective Agents in Parkinson's Disease Targeting Oxidative Stress.
    Hor SL; Teoh SL; Lim WL
    Curr Drug Targets; 2020; 21(5):458-476. PubMed ID: 31625473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70.
    Mandel S; Grunblatt E; Riederer P; Amariglio N; Jacob-Hirsch J; Rechavi G; Youdim MB
    Ann N Y Acad Sci; 2005 Aug; 1053():356-75. PubMed ID: 16179542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidants as therapy for Parkinson's disease.
    Shults CW
    Antioxid Redox Signal; 2005; 7(5-6):694-700. PubMed ID: 15890014
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of pharmacological agents on the lifespan phenotype of Drosophila DJ-1beta mutants.
    Lavara-Culebras E; Muñoz-Soriano V; Gómez-Pastor R; Matallana E; Paricio N
    Gene; 2010 Aug; 462(1-2):26-33. PubMed ID: 20423725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of neuromotor deficits by natural antioxidants of Decalepis hamiltonii in transgenic Drosophila model of Parkinson's disease.
    Jahromi SR; Haddadi M; Shivanandappa T; Ramesh SR
    Neuroscience; 2015 May; 293():136-50. PubMed ID: 25754960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.